Ceva Sante Animale has acquired Canadian poultry vaccine manufacturer Vetech Laboratories Inc.

According to Ceva CEO Marc Prikazsky, the move allows the company to expand its poultry vaccine range from respiratory to include intestinal health.


“Bringing the Immucox products into the Ceva portfolio demonstrates our continued commitment to the poultry industry,” said Craig Wallace, director of Ceva’s North American operations. “Poultry protein is an important food source around the world. Protecting the global supply of high-quality poultry meat and eggs to the growing population is critical, and it’s why Ceva continues to dedicate resources to poultry vaccination technology.”

Production of Immucox will remain primarily in Canada. The company plans to deploy certain technologies in the U.S. with this specific virus strain.